Atlas Trials

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Clinical trial NCT05371860 · WITHDRAWN

Trial details

NCT number
NCT05371860
Sponsor
Armando Giuliano
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerHER2-positive Breast Cancer
Start date
2023-07-01
Primary completion
2028-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.